{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:51:23Z","timestamp":1776131483218,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,14]]},"DOI":"10.7759\/cureus.47027","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:04:00Z","timestamp":1697303040000},"source":"Crossref","is-referenced-by-count":1,"title":["Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement"],"prefix":"10.7759","author":[{"given":"Hassan O","family":"Yera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olawale M","family":"Akinlade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asgher","family":"Champsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Nam J","family":"Glouzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha BM","year":"2018","unstructured":"Rocha BM, Cunha GJ, Menezes Falc\u00e3o LF. The burden of iron deficiency in heart failure: therapeutic approach. J Am Coll Cardiol. 2018, 71:782-93. 10.1016\/j.jacc.2017.12.027","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska EA","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al.. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31:1872-80. 10.1093\/eurheartj\/ehq158","journal-title":"Eur Heart J"},{"key":"ref3","unstructured":"Society of Cardiothoracic Surgery. (2023). Accessed. 10\/10\/2023: https:\/\/scts.org\/patients\/hospitals\/97\/new_cross_hospital."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the Ironout HF Randomized Clinical trial","volume":"317","author":"Lewis GD","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, et al.. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the Ironout HF Randomized Clinical trial. JAMA. 2017, 317:1958-66. 10.1001\/jama.2017.5427","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip IT","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, et al.. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013, 165:575-582.e3. 10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease","volume":"12","author":"von Haehling S","year":"2015","unstructured":"von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015, 12:659-69. 10.1038\/nrcardio.2015.109","journal-title":"Nat Rev Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1202","article-title":"Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study","volume":"20","author":"Iorio A","year":"2018","unstructured":"Iorio A, Senni M, Barbati G, et al.. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study. Eur J Heart Fail. 2018, 20:1257-66. 10.1002\/ejhf.1202","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand IS","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018, 138:80-98. 10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1305","article-title":"Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice","volume":"20","author":"McDonagh T","year":"2018","unstructured":"McDonagh T, Damy T, Doehner W, et al.. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018, 20:1664-72. 10.1002\/ejhf.1305","journal-title":"Eur J Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management","author":"Cappellini MD","year":"2017","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, et al.. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. 2017. 10.1002\/ajh.24820"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko DO","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011, 58:1241-51. 10.1016\/j.jacc.2011.04.040","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker SD","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al.. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361:2436-48. 10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study","volume":"34","author":"Comin-Colet J","year":"2013","unstructured":"Comin-Colet J, Lainscak M, Dickstein K, et al.. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J. 2013, 34:30-8. 10.1093\/eurheartj\/ehr504","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski P","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J. 2015, 36:657-68. 10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos G","year":"2013","unstructured":"Filippatos G, Farmakis D, Colet JC, et al.. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail. 2013, 15:1267-76. 10.1093\/eurjhf\/hft099","journal-title":"Eur J Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska EA","year":"2016","unstructured":"Jankowska EA, Tkaczyszyn M, Suchocki T, et al.. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016, 18:786-95. 10.1002\/ejhf.473","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker SD","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, et al.. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018, 20:125-33. 10.1002\/ejhf.823","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh TA","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022, 24:4-131. 10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2879","article-title":"Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project","volume":"25","author":"Lindberg F","year":"2023","unstructured":"Lindberg F, Lund LH, Benson L, Linde C, Orsini N, Carrero JJ, Savarese G. Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project. Eur J Heart Fail. 2023, 25:1270-80. 10.1002\/ejhf.2879","journal-title":"Eur J Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179740-improving-the-outcome-of-patients-with-heart-failure-assessment-of-iron-deficiency-and-intravenous-iron-replacement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:10Z","timestamp":1707509170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179740-improving-the-outcome-of-patients-with-heart-failure-assessment-of-iron-deficiency-and-intravenous-iron-replacement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.47027","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,14]]}}}